Selank 5mg

PRODUCT OVERVIEW Anxiolytic Peptide
ACNE No
WATER RETENTION No
HBR No
HEPATOTOXICITY No
AROMATIZATION No
MANUFACTURER Beligas
WAREHOUSE International Warehouse 3
ACTIVE INGREDIENT Selank

In the rapidly advancing field of biotechnology, exciting discoveries of biologically active substances, particularly "cognitive enhancers" or "nootropics," are making waves. One standout is Selank, previously known as ?TP-7.? This synthetic peptide, a small, engineered protein, is gaining attention for its remarkable properties.

Renowned for its anti-anxiety effects, Selank is also said to enhance cognitive performance and energy levels, all while minimizing side effects and addiction risks. Developed at the prestigious Institute of Molecular Genetics (Russian Academy of Sciences) in partnership with the V.V. Zakusov Research Institute of Pharmacology, Selank emerged alongside its counterpart, Semax.

Selank combines the sequence of tuftsin, a natural peptide found in IgG antibodies, with additional elements to enhance its stability. Studies indicate that both tuftsin and Selank can reduce anxiety and elevate serotonin levels in rats, with Selank showing slightly superior results.

While Selank is approved in Russia for treating generalized anxiety disorder (GAD) and as a nootropic, it has not yet received FDA approval in the U.S. Nevertheless, it is available in many countries as a "nutritional supplement," making it accessible for those seeking cognitive support.

The exact mechanisms behind Selank remain partially understood, but it is believed to stabilize enkephalins in the bloodstream?natural peptides that can help modulate stress responses. However, a study on mice did not confirm this stabilization, nor did it demonstrate significant anti-anxiety effects from Selank alone.

Some cellular research suggests Selank may interact with GABA receptors, typically inducing calming effects. In treated mice, increased activity in GABA-dependent inhibitory neurons was observed, leading to reduced overall brain activity. Additionally, Selank has shown potential in elevating BDNF (brain-derived neurotrophic factor), vital for brain development and associated with memory and learning, hinting at its cognitive benefits.

Selank also appears to influence neurotransmitter levels, including norepinephrine, dopamine, and serotonin, all crucial for motivation, focus, and pleasure. However, results vary, with some studies indicating differing effects on these neurotransmitters, underscoring the need for further exploration.

In an initial clinical trial with 62 participants, Selank demonstrated a reduction in anxiety symptoms, particularly among those with existing anxiety disorders. Another study involving 60 patients experiencing anxiety and phobias noted similar positive outcomes, with effects lasting up to a week post-treatment.

Furthermore, in a trial with 70 anxiety patients, Selank enhanced the effects of phenazepam (a restricted anti-anxiety medication in certain U.S. states) while minimizing adverse effects like drowsiness and memory issues. Animal studies corroborate these findings, as Selank has shown anxiety-reducing properties in mice, especially those exhibiting higher baseline anxiety levels.

While the evidence is promising, further research is essential to confirm Selank?s efficacy and safety in humans. It is advisable for individuals with anxiety to consult a healthcare professional before considering Selank as a treatment option.

A 30-day study suggested Selank may help stabilize memory traces in rats, although the assessment methods were not clearly defined. Another study indicated potential memory preservation in monkeys, but reliable human data is still lacking, warranting further investigation into Selank's effects on healthy individuals.

Research indicates that Selank may restore normal brain activity in rats suffering from toxin-induced brain damage.

Selank has been observed to alleviate symptoms of depression in mice, particularly at lower doses, as indicated by reduced immobility in forced swimming tests.

Preliminary animal studies suggest that Selank injections can boost antioxidant levels in the livers of stressed mice.

In sedated cats, Selank was found to temporarily lower blood pressure by about 30% while enhancing brain blood flow by approximately 24% for up to 10 minutes. While intriguing, these results highlight the need for further research to ascertain their clinical relevance.

In a study, rats experiencing alcohol withdrawal exhibited reduced anxiety levels after Selank treatment, suggesting potential benefits in managing withdrawal symptoms.

Research involving rats on a high-fat diet indicated that Selank-treated subjects experienced 35% less weight gain, alongside significant reductions in total cholesterol and blood glucose levels.

In a study, Selank administration in mice with breast cancer resulted in slower tumor growth and prolonged lifespans compared to untreated subjects. However, this finding does not imply Selank is a viable cancer treatment and necessitates extensive research before clinical applications are considered.

Selank treatment correlated with increased levels of inflammatory response genes in mouse spleens, possibly indicating protective effects against inflammation-related damage.

Selank has shown promise in reducing stomach ulcer size in animal models, potentially by enhancing lymphatic flow to the stomach. However, human studies are needed to confirm these effects.

In depressive patients, Selank has been linked to increased IL-6 levels, an inflammatory protein essential for combating infections. Additionally, Selank has been shown to stimulate the release of interferons, which serve as antiviral agents, though evidence of its antiviral efficacy is still inconclusive.